We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.07B
1-Year Est. Return 78.71%
This Fund
S&P 500
This Quarter Est. Return
+14.23%
1 Year Est. Return
+78.71%
3 Year Est. Return
+323.31%
5 Year Est. Return
+574.14%
10 Year Est. Return
+3,824.29%
AUM
$2.8B
AUM Growth
+$635M
Cap. Flow
+$218M
Cap. Flow %
7.79%
Top 10 Hldgs %
49.77%
Holding
313
New
122
Increased
18
Reduced
66
Closed
70

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$183M
2
ESGR
Enstar Group
ESGR
+$157M
3
BPMC
Blueprint Medicines
BPMC
+$138M
4
SKX
Skechers
SKX
+$137M
5
DNB
Dun & Bradstreet
DNB
+$129M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$208M
2
PDCO
Patterson Companies, Inc.
PDCO
+$149M
3
ATSG
Air Transport Services Group
ATSG
+$95M
4
PLYA
Playa Hotels & Resorts
PLYA
+$93.6M
5
SWI
SolarWinds Corporation Common Stock
SWI
+$90.9M

Sector Composition

Rank Sector Weight
1 Financials 32.71%
2 Miscellaneous 18.12%
3 Healthcare 14.93%
4 Consumer Discretionary 10.35%
5 Industrials 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VCIC
151
DELISTED
Vine Hill Capital Investment Corp
VCIC
$307K 0.01%
29,520
– –
RTAC
152
Renatus Tactical Acquisition Corp I
RTAC
$329M
$295K 0.01%
+25,000
New +$287K
CRAQR
153
Cal Redwood Acquisition Corp Right
CRAQR
$282K 0.01%
+1,044,730
New +$272K
RDAGW
154
Republic Digital Acquisition Co Warrants
RDAGW
$4.24M
$252K 0.01%
+399,451
New +$347K
SBXD
155
SilverBox Corp IV
SBXD
$276M
$219K 0.01%
20,000
+1,216
+6% +$12.7K
TONT
156
Graf Global Corp
TONT
$154M
$189K 0.01%
+18,104
New +$187K
AACBR
157
DELISTED
Artius II Acquisition Inc Rights
AACBR
$185K 0.01%
+771,348
New +$173K
DMAAR
158
Drugs Made In America Acquisition Corp Rights
DMAAR
$156K 0.01%
1,300,000
– –
GTENW
159
Gores Holdings X Warrants
GTENW
$147K 0.01%
+249,592
New +$149K
SDHIR
160
Siddhi Acquisition Corp Right
SDHIR
$133K ﹤0.01%
+580,000
New +$129K
FACWW
161
Factorial Energy Inc Warrant
FACWW
$10.4M
$133K ﹤0.01%
+493,040
New +$144K
PMTRW
162
Perimeter Acquisition Corp I Warrant
PMTRW
$127K ﹤0.01%
+198,600
New +$133K
IPEXR
163
Inflection Point Acquisition Corp V Rights
IPEXR
$120K ﹤0.01%
443,050
-151,514
-25% -$40K
KFIIR
164
K&F Growth Acquisition Corp II Rights
KFIIR
$112K ﹤0.01%
899,991
-275,009
-23% -$37.4K
DRDBW
165
Roman DBDR Acquisition Corp II Warrants
DRDBW
$1.84M
$103K ﹤0.01%
205,000
-37,162
-15% -$15K
ATIIW
166
Archimedes Tech SPAC Partners II Co Warrant
ATIIW
$16.3M
$101K ﹤0.01%
+249,938
New +$77.2K
GSRTR
167
DELISTED
GSR III Acquisition Corp Right
GSRTR
$99K ﹤0.01%
14,500
-78,224
-84% -$292K
RAAQW
168
DELISTED
Real Asset Acquisition Corp Warrants
RAAQW
$99K ﹤0.01%
+214,996
New +$88.5K
PELIR
169
DELISTED
Pelican Acquisition Corp Right
PELIR
$91K ﹤0.01%
+481,335
New +$87.5K
HVIIR
170
Hennessy Capital Investment Corp VII Rights
HVIIR
$90K ﹤0.01%
300,000
-441,007
-60% -$125K
LOKVW
171
DELISTED
Live Oak Acquisition Corp V Warrants
LOKVW
$87K ﹤0.01%
+124,900
New +$63.3K
XRPNW
172
Armada Acquisition Corp II Warrant
XRPNW
$12.2M
$85K ﹤0.01%
+313,783
New +$87.9K
DAAQW
173
Digital Asset Acquisition Corp Warrant
DAAQW
$84K ﹤0.01%
+99,098
New +$94K
HDRNW
174
Hadron Energy Warrant
HDRNW
$3.2M
$83K ﹤0.01%
549,999
-186,460
-25% -$18.6K
JACS.RT
175
Jackson Acquisition Co II Rights
JACS.RT
$81K ﹤0.01%
300,000
-250,000
-45% -$61.5K
5 6
7
8 9

Similar funds

PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.57% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

Glazer Capital LLC's Q2 2025 Portfolio in Review

As of Q2 2025, Glazer Capital LLC held 313 positions worth $2.8B, up 29% from $2.16B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Glazer Capital LLC deployed $218M of net new capital in Q2 2025, opening 122 new positions and adding to 18 existing holdings. Its largest new stake was SpringWorks Therapeutics: 4,107,199 shares worth $193M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $78.8M trimmed.

  • Glazer Capital LLC's largest Q2 2025 buy was SpringWorks Therapeutics: 4,107,199 shares worth $193M.
  • Glazer Capital LLC added most to Enstar Group in Q2 2025, an estimated $157M increase.
  • Glazer Capital LLC's biggest Q2 2025 reduction was Kellanova, cutting an estimated $78.8M.
  • Glazer Capital LLC fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $208M.
  • Glazer Capital LLC's ten largest holdings make up 50% of its $2.8B portfolio in Q2 2025.
  • Glazer Capital LLC opened 122 new positions and closed 70 in Q2 2025.
  • Glazer Capital LLC's portfolio value rose 29% quarter-over-quarter to $2.8B.

Based on Glazer Capital LLC's 13F filing for Q2 2025, filed 14 Aug 2025.